6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions
About 3.8 million people in the United States — four times the number two years ago — are now taking the most popular weight-loss drugs, according to the IQVIA Institute for Human Data Science, an industry data provider.Some of these prescriptions are for diabetes. The medicines are Novo Nordisk’s Ozempic and Wegovy (the same drug sold under different brand names), and Eli Lilly’s Mounjaro and Zepbound (also the same drug).Pent-up demand is even higher, because many people who want the drugs cannot find or afford them. Without insurance coverage, people have to pay out of their own pockets. If they obtain a coupon offering a discount from Eli Lilly, people with commercial insurance pay $550 a month for Zepbound. For those who are commercially insured, a coupon from Novo Nordisk for Wegovy ...